Cargando...
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer-related deaths worldwide. However, significant progress has been made individualizing therapy based on molecular aberrations (e.g., EGFR, ALK) and pathologic subtype. KRAS is one of the most frequently mutated genes in non-small cell lung cancer (NSCLC...
Gardado en:
| Publicado en: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AlphaMed Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153335/ https://ncbi.nlm.nih.gov/pubmed/27807303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0084 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|